000 | 02087 a2200565 4500 | ||
---|---|---|---|
005 | 20250515014539.0 | ||
264 | 0 | _c20060606 | |
008 | 200606s 0 0 eng d | ||
022 | _a1600-6135 | ||
024 | 7 |
_a10.1111/j.1600-6143.2005.01211.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aElstrom, R L | |
245 | 0 | 0 |
_aTreatment of PTLD with rituximab or chemotherapy. _h[electronic resource] |
260 |
_bAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons _cMar 2006 |
||
300 |
_a569-76 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
650 | 0 | 4 |
_aDoxorubicin _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLymphoproliferative Disorders _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOrgan Transplantation _xadverse effects |
650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRituximab |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVincristine _xtherapeutic use |
700 | 1 | _aAndreadis, C | |
700 | 1 | _aAqui, N A | |
700 | 1 | _aAhya, V N | |
700 | 1 | _aBloom, R D | |
700 | 1 | _aBrozena, S C | |
700 | 1 | _aOlthoff, K M | |
700 | 1 | _aSchuster, S J | |
700 | 1 | _aNasta, S D | |
700 | 1 | _aStadtmauer, E A | |
700 | 1 | _aTsai, D E | |
773 | 0 |
_tAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons _gvol. 6 _gno. 3 _gp. 569-76 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-6143.2005.01211.x _zAvailable from publisher's website |
999 |
_c16081689 _d16081689 |